Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays.

[1]  R. Lanciotti,et al.  Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.

[2]  R. Césaire,et al.  Dengue Seroprevalence in the French West Indies: A Prospective Study in Adult Blood Donors , 2015, The American journal of tropical medicine and hygiene.

[3]  S. Cassadou,et al.  Zika emergence in the French Territories of America and description of first confirmed cases of Zika virus infection on Martinique, November 2015 to February 2016. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  J. Schmidt-Chanasit,et al.  High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  E. Lattwein,et al.  Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016 , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  R. Charrel,et al.  Background review for diagnostic test development for Zika virus infection , 2016, Bulletin of the World Health Organization.

[7]  M. Drebot,et al.  Evaluation of 5 Commercially Available Zika Virus Immunoassays , 2017, Emerging infectious diseases.

[8]  Eli Schwartz,et al.  Sensitivity and Kinetics of an NS1-Based Zika Virus Enzyme-Linked Immunosorbent Assay in Zika Virus-Infected Travelers from Israel, the Czech Republic, Italy, Belgium, Germany, and Chile , 2017, Journal of Clinical Microbiology.

[9]  Louis Papageorgiou,et al.  Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing , 2017, Journal of Clinical Microbiology.

[10]  A. García-Sastre,et al.  Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity , 2017, Science.

[11]  L. Kramer,et al.  A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis , 2017, EBioMedicine.

[12]  Sarah L. Keasey,et al.  Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity , 2017, Clinical and Vaccine Immunology.

[13]  M. Hoelscher,et al.  Long-term kinetics of Zika virus RNA and antibodies in body fluids of a vasectomized traveller returning from Martinique: a case report , 2017, BMC Infectious Diseases.

[14]  L. Kramer,et al.  A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients , 2017, EBioMedicine.

[15]  C. Pasquier,et al.  Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study. , 2017, The Lancet. Infectious diseases.

[16]  K. St. George,et al.  Laboratory Diagnosis of Zika Virus Infection. , 2017, Archives of pathology & laboratory medicine.